Fundraising FoxNorthpond Ventures — 2022 Investments
17 investments dated 2022 · listed companies and verified rows first · show all
Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.
BiotechEmeryville, US
Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in
Co-investorsBain Capital Life SciencesVida VenturesWestlake Village BioPartnersGilead SciencesInsight PartnersKleiner Perkins+3 more
OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs.
BiotechDeep TechDigital HealthHealthtechMedical DevicesOxford, GB
Professor Dame Carol Robinson(Founder and Chair of Scientific Advisory Board)Idlir Liko(Founder)inJonathan Hopper(Vice President, Platforms and Founder)inHsin Yung (Jason) Yen(Founder)inRos Deeganin
Co-investorsGV (Google Ventures)Oxford Science EnterprisesSanofi Ventures
QbDVision provides a software platform designed to address digital transformation challenges in pharmaceutical and biotech manufacturing, helping companies manage compliance, quality, and process development.
BiotechCloud ComputingEnterprise SoftwareHealthtechSaaSAustin, US
Yash Sabharwal(President, CEO, Co-Founder)inRyan Shillington(CTO, CISO, Co-Founder)in
Co-investorsS3 VenturesCartmell VenturesCREATE HEALTH VENTURES
En Plus One Bio develops synthesis and manufacturing technology for RNA therapeutics, focused on producing high-purity long RNA with higher cycle efficiencies and novel chemical modifications.
BiotechDeep TechWatertown, US
Daniel Ahlstedt(Executive Officer, Director)inJonathan Rittichier(Founder)inDaniel Wiegand(Founder)George M. Church(Founder)
BoardAndrew Lee(Director)in
Board seatPaxton Major· per SEC Form D
Co-investorsBreakout VenturesCoatue Management
64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics.
BiotechDeep TechMedical Devices
Co-investorsBoxGroupFirst Round CapitalFifty YearsFuture VenturesLifeforce CapitalRefactor Capital+1 more
64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Lexi Rovner(CEO, Co-founder, Board of Directors)inAlexis Rovner(Founder)Ryan GallagherEmily Hawkins(Head of Talent)George Church, PhD(Co-founder, Scientific Advisory Board)David Thompson, PhD(Co-founder, Scientific Advisory Board)
Co-investorsFifty YearsFuture VenturesG VenturesLifeforce CapitalRaptor GroupY Combinator+8 more
QbDVision develops a Digital CMC (Chemistry, Manufacturing, and Controls) platform that captures structured product and process data to support end-to-end product lifecycle management from R&D through commercial manufacturing.
AI & Machine LearningBiotechSaaSAustin, US
Yashvinder Sabharwal(Executive Officer, Director)Ryan Shillington(Executive Officer, Director)
Co-investorsATX Venture Partners
Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.
BiotechDeep TechHealthtechHatfield, US
Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)Brian McVeigh(Executive Officer, Director)in
BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)4BIO CapitalAmgen VenturesHatteras Venture PartnersJDRF T1D FundTakeda Ventures+1 more
General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.
Deep TechHealthtechMedical Devices
Co-investorsOMX VenturesPaladin Capital GroupGenoa VenturesVertical Venture Partners
Douglas Hanahan(Founder)Gideon Bollag(Founder)Joseph Schlessinger(Founder)
Co-investorsLongitude CapitalMenlo Ventures
Opt Industries engineers advanced materials using digital photolithography to create structured materials with precise microstructure control, enabling functional properties across applications from high-speed interconnects to fluid handling.
Advanced ManufacturingDeep TechNew MaterialsMedford, US
Jifei Ou(Founder)in
Co-investorsCrosslink CapitalGaingelsGrit VenturesThe E14 FundBlumberg CapitalGradient Ventures
__Twitter.png)
Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.
Construction TechHardwareImpact & Social GoodPropTech
Hasier Larrea(Founder)
Co-investorsIngka InvestmentsPresidio VenturesThe E14 FundAmadeus Capital PartnersDelin VenturesEpisode1+4 more
ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.
AI & Machine LearningLogistics & Supply ChainSaaS
Brant Slade(Founder)in
Co-investorsKickstartAmadeus Capital PartnersDelin VenturesKhosla VenturesNovalis LifeSciencesOctopus Ventures+2 more
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersKindred CapitalNovalis LifeSciencesOctopus VenturesDelin VenturesPuhua Capital
The company develops diagnostics and biological sample collection devices, including a rapid sickle-cell test, supporting infectious disease detection and genomic, metabolomic, and microbiome research.
BiotechHealthtechMedical DevicesCambridge, US
Rahul Dhanda(Executive Officer, Director)inJames Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPGaingelsIllumina VenturesCatalio Capital ManagementGood VenturesGV (Google Ventures)+1 more
AgTechEmeryville, US
Eric Davidson(Director)inTravis Bayer(Director)inPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)inDerek Norman(Director)in
Co-investorsCavallo VenturesCultivian Sandbox VenturesFall Line CapitalS2G InvestmentsFootPrint CoalitionLeaps by Bayer+2 more
Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.
AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US
Lewis Williams(Co-founder & CEO)inRusty Williams(Founder)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)
Co-investorsFirst Spark Ventures, LlcPandect BioventuresIllumina Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.